Oculis
high unmet need for novel treatments for efficacy onset tolerability | Oculis
Company
Deck Type
Deck date
April 2024
Slide
26 of 48
Related slides by other companies
Exscientia
Results
May 2022
the exalt trial i a be | Exscientia
Erasca
Investor Presentation
January 2024
eras could address high unmet need in patients in us and | Erasca
Alkermes
Investor Day
March 2021
developing new treatments to address unmet patient need in and oncology optimizing for success executive vice president and chief medical officer alkermes | Alkermes
Other recent decks by Oculis
See all presentations (7 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Results
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io